How is the dose of Insulin 70/30 (Novolin 70/30, NPH/Regular Insulin) calculated for a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin 70/30 Dose Calculation

For insulin-naive patients, start with 10 units daily or 0.1-0.2 units/kg/day, divided as 2/3 before breakfast and 1/3 before dinner; for patients converting from NPH insulin, calculate 80% of the current NPH total daily dose and split it the same way. 1

Initial Dosing for Insulin-Naive Patients

  • Start with 10 units per day or 0.1-0.2 units/kg per day for patients beginning insulin therapy, as recommended by the American Diabetes Association 1
  • Divide the total daily dose into 2/3 before breakfast and 1/3 before dinner 1, 2
  • For example, if starting with 30 units total daily dose: give 20 units before breakfast and 10 units before dinner 1

Converting from NPH Insulin to 70/30

  • Calculate 80% of the current NPH total daily dose (not 100%) to avoid hypoglycemia during transition 1, 2
  • Distribute this reduced dose as 2/3 before breakfast and 1/3 before dinner 1, 2
  • For example, if a patient takes 50 units NPH daily: calculate 50 × 0.8 = 40 units total, then give approximately 27 units before breakfast and 13 units before dinner 1, 2

Critical Pitfall to Avoid

Never convert on a 1:1 basis from NPH to 70/30 insulin, as this significantly increases hypoglycemia risk 1, 2. The American College of Endocrinology specifically warns against this common error 1.

Dose Titration Algorithm

  • Monitor fasting plasma glucose (FPG) and set target of 90-150 mg/dL (4.0-7.0 mmol/L) 2, 3
  • Increase the dose by 2 units every 3 days until reaching FPG goal without hypoglycemia 1
  • If hypoglycemia occurs, determine the cause and reduce the corresponding dose by 10-20% if no clear reason is identified 1
  • If A1C is <8% at baseline, consider lowering the calculated dose to avoid hypoglycemia during transition 1, 2

Monitoring Requirements During Transition

  • Check blood glucose more frequently during the transition period, focusing on both fasting and postprandial levels 1, 2
  • This is when hypoglycemia risk is highest, and neglecting monitoring is a common pitfall 1
  • Target fasting glucose between 72-126 mg/dL (4.0-7.0 mmol/L) 2
  • Research demonstrates that frequent clinic visits (biweekly) combined with sliding scale adjustments significantly improved glycemic control in patients using 70/30 insulin 4

Essential Clinical Considerations

  • Consistent meal timing is particularly critical with premixed insulin regimens to avoid hypoglycemia 1, 2
  • 70/30 insulin provides both basal and prandial coverage with fewer daily injections, simplifying the regimen compared to separate basal-bolus injections 1, 2
  • The morning dose should typically be higher than the evening dose—never use the same dose for both injections 1, 2
  • Clinical trial data shows that 70/30 insulin algorithms achieve superior glycemic control compared to traditional sliding scale insulin dosing in hospitalized patients 5

Practical Dosing Example

For a 70 kg patient starting insulin therapy:

  • Calculate: 70 kg × 0.15 units/kg = 10.5 units total daily dose 1
  • Round to 12 units for practical dosing 1
  • Morning dose: 12 × 2/3 = 8 units before breakfast 1
  • Evening dose: 12 × 1/3 = 4 units before dinner 1

References

Guideline

Insulin 70/30 Dosing and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Switching from NPH Insulin to 70/30 Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Preventing Overlapping of Insulin Regimens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2021

Research

70/30 insulin algorithm versus sliding scale insulin.

The Annals of pharmacotherapy, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.